Evaluation of the effect of tetravalent (A, C, Y, W-135) meningococcal conjugate vaccine [meningococcal vaccine groups A C Y W-135 conjugate] on serogroup-specific carriage of Neisseria meningitidis

Trial Profile

Evaluation of the effect of tetravalent (A, C, Y, W-135) meningococcal conjugate vaccine [meningococcal vaccine groups A C Y W-135 conjugate] on serogroup-specific carriage of Neisseria meningitidis

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Mar 2007

At a glance

  • Drugs Meningococcal vaccine groups A C Y W-135 conjugate (Primary)
  • Indications Meningococcal infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top